World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
24465
World Ranking
2279
National Ranking
1105

Best Publications

  • Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives

  • Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

    R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd

  • Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C natural killer cells with potent function

    Bree Foley;Sarah Cooley;Michael R. Verneris;Michelle Pitt

  • Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

    Claudio G. Brunstein;Jonathan A. Gutman;Daniel J. Weisdorf;Ann E. Woolfrey

  • Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

    Elena J. Orlando;Xia Han;Catherine Tribouley;Patricia A. Wood

  • Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.

    Michael R. Verneris;Michael R. Verneris;Mobin Karami;Mobin Karami;Jeanette Baker;Jeanette Baker;Anishka Jayaswal;Anishka Jayaswal

  • Clearance of Acute Myeloid Leukemia by Haploidentical Natural Killer Cells Is Improved Using IL-2 Diphtheria Toxin Fusion Protein

    Veronika Bachanova;Sarah Cooley;Todd E. Defor;Michael R. Verneris

  • Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

    Matthias Edinger;Yu An Cao;Michael R. Verneris;Michael H. Bachmann

  • Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

    Bree Foley;Sarah A Cooley;Michael R Verneris;Julie M Curtsinger

  • Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

    Claudio G. Brunstein;Jeffrey S. Miller;David H. McKenna;Keli L. Hippen

  • First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

    Rizwan Romee;Sarah Cooley;Melissa M. Berrien-Elliott;Peter Westervelt

  • Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

    Michelle K. Gleason;Todd R. Lenvik;Valarie McCullar;Martin Felices

  • IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

    Daniel A. Vallera;Martin Felices;Ron McElmurry;Valarie McCullar

  • Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

    Jeffery S. Miller;Sarah Cooley;Peter Parham;Sherif S. Farag

  • Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

    Michael R. Verneris;Claudio G. Brunstein;Juliet Barker;Margaret L. MacMillan

  • Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.

    Petter S. Woll;Bartosz Grzywacz;Xinghui Tian;Rebecca K. Marcus

  • Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production

    Jeanette Baker;Michael R. Verneris;Maki Ito;Judith A. Shizuru

  • Advancing animal models of neoplasia through in vivo bioluminescence imaging.

    M. Edinger;Y.-a. Cao;Y.S. Hornig;D.E. Jenkins

  • One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers

    John E. Wagner;Mary Eapen;Shelly Carter;Yanli Wang

  • CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

    Michelle K. Gleason;Julie A. Ross;Erica D. Warlick;Troy C. Lund

Frequent Co-Authors

Jeffrey S. Miller
Jeffrey S. Miller University of Minnesota
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
John E. Wagner
John E. Wagner University of Minnesota
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Todd E. DeFor
Todd E. DeFor University of Minnesota
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin
Katharine C. Hsu
Katharine C. Hsu Memorial Sloan Kettering Cancer Center
Angela Panoskaltsis-Mortari
Angela Panoskaltsis-Mortari University of Minnesota
Robert S. Negrin
Robert S. Negrin Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Michael R. Verneris